Myelodysplastic syndromes: open trials in Switzerland

• NCT06499285

  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  Trial Treatment · Phase 3 · Takeda

  University Hosptial Basel, Basel · Insel Gruppe AG, University Clinic for Hematology and Central Hematological Laboratory, Bern · Universitatsspital Zurich, Klinik fur Medizinische Onkologie und Hamatologie, Zurich

  Registry updated 2026-11-06

• NCT07422480

  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  Trial Treatment · Phase 3 · Takeda

  Insel Gruppe AG, Bern · Kantonsspital Graubunden, Chur · Universitätsspital Zürich, Zurich

  Registry updated 2026-11-06

• NCT04996875

  (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  Trial Treatment · Phase 2 · Cogent Biosciences, Inc.

  Universitätsspital Basel, Basel

  Registry updated 2026-09-15

• NCT04988555

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.

  University Hospital Basel, Basel · University Hospital Bern / Inselspital, Bern · Universitaetsspital Zuerich - Haematology, Zurich

  Registry updated 2026-03-24

• NCT03300492

  Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

  Trial Treatment · Phase 1/2 · University Hospital, Basel, Switzerland

  University Hospital Basel, Basel

  Registry updated 2025-12-04

All Myelodysplastic syndromes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error